Buy, hold, sell: Mineral Resources, Ansell, CBA shares

Let's check out some new ratings for these ASX 200 shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares are down 0.3% to 9,051.6 points on Tuesday.

Let's check out some new ratings for ASX 200 shares this week.

A woman has a quizzical look on her face as though she is deciding something in the foreground of a backdrop featuring five stars, like the Australian five star energy rating system.

Image source: Getty Images

Mineral Resources Ltd (ASX: MIN)

The Mineral Resources share price is $64.27, down 0.6% today and up 74% over 12 months. 

Bell Potter has a buy rating on this ASX 200 mining share. 

Analyst James Williamson said: 

MIN reported record FY26 underlying EBITDA of $2.6b (BPe $2.5b; VA cons. $2.5b) and underlying NPAT of $822m (BPe $774m; VA consensus $765m). Statutory NPAT was $1.2b (BPe $1.1b; VA cons. $966m) with $393m non-recurring items.

Completion of the US$765m MIN-POSCO lithium transaction will accelerate balance sheet deleveraging paired with strong cash flows from iron ore and lithium operations.

MIN's mining services platform delivers a stable earnings stream that is expected to expand with internal and third-party volume growth.

The company is strongly positioned to execute its next phase of growth, having reinstated dividends.

Ansell Ltd (ASX: ANN)

The Ansell share price is $40.52, down 0.6% today and up 17% over 12 months. 

Morgans has a hold rating on this ASX 200 healthcare share

The broker said: 

FY26 result was strong, with adjusted EPS of US148.6c (+18%) at the top end of guidance, with adjusted EBIT of US$322m (+15% organic cc) above our forecast.

Importantly, 2H adjusted sales growth accelerated to 9.2%, with volumes improving providing some evidence that volume recovery is emerging.

While FY27 EPS guidance of US158-170c (6-14%) looks solid, the majority of gains comes from FX and buybacks rather than operating earnings, with sustainability of Healthcare growth and Industrial margins yet to be proven.

We increase FY27-28 EPS forecasts up to 5.9%, with our DCF/SOTP price target increasing to A$37.85.

Commonwealth Bank of Australia (ASX: CBA)

The CBA share price is $160.25, up 0.2% today and down 5% over 12 months. 

Remo Greco from Sanlam Private Wealth has a sell rating on this ASX 200 bank share

On The Bull this week, Greco said:   

This leading Australian bank posted cash net profit after tax of $10.982 billion in full year 2026, up 7 per cent on the prior corresponding period.

Revenue from ordinary activities of $30.153 billion was up 7 per cent. Investors are concerned about slowing housing credit growth.

Home loan applications fell about 15 per cent since the federal budget in May and the company's full year result in August.

Mortgage competition remains elevated. Investors may want to consider cashing in some gains until a clearer picture emerges about the state of Australia's housing market, the outlook for interest rates and the broader outlook for credit growth moving forward.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ansell. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two work colleagues looking at a laptop and discussing something.
Broker Notes

Buy, hold, sell: Boss Energy, Magellan, and NextDC shares

Morgans has given its verdict on these shares following earnings season.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Up 75%! Why this rocketing ASX All Ords stock is forecast to deliver more outsized gains

A top broker forecasts more outperformance from this soaring ASX stock. But why?

Read more »

Hand stacking increasing piles of rocks.
Broker Notes

5 ASX 200 shares with 33% to 61% upside post-results: experts

As earnings season comes to a close, here are the new 12-month price targets from the experts.

Read more »

Two scientists analysing results on a computer screen.
Broker Notes

Up 88%! Why CSL shares remain an 'appealing' buy today

A top analyst forecasts more outperformance from CSL’s surging shares.

Read more »

A mining worker wearing a hard hat, orange high vis vest, and blue long-sleeved shirt raises his fists in celebration with an excited expression on his face.
Broker Notes

Up 56%! 3 reasons to still buy BHP shares today

A top analyst forecasts more outperformance from BHP’s soaring shares.

Read more »

A female scientist in a laboratory setting using a tablet to review data, with a male scientist working in the background.
Broker Notes

Why 4DMedical shares could still rise 65%

This popular stock could still have major upside potential according to Bell Potter.

Read more »

Two miners laughing and having fun while using smart phone during their coffee break.
Resources Shares

Buy, hold, sell: Rio Tinto, PLS Group, BHP shares

BHP shares hit a record high of $68.77 last week. Is the miner a buy, hold, or sell at this…

Read more »

Couple on their laptop in their home kitchen.
Broker Notes

Experts name 2 ASX 200 blue chip shares to buy this week

Morgans has named two of the biggest names on the Australian share market as buys.

Read more »